Immatics at The International Conference on Lymphocyte Engineering (Sept 13-15) in London, UK

| News, USA

Health innovators in immune-gene therapy coming together

Meet Immatics at this year’s ICLE, discuss engineering approaches and get a dedicated ACTallo® update:


Saturday, Sept 14, 12.20pm – 12.35pm UK time

Session 4: TCR for the treatment of solid tumors

ACTallo®: Using TCR-engineered allogeneic gamma-delta T cells to treat cancer

Speaker: Mamta Kalra, Assoc. Director CMC


Further information on ICLE 2019 here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.